1 宋妮,温永俊,王凤,等. 利用SUMO表达系统高效表达猪O型口蹄疫病毒VP0、VP1、VP3基因[J]. 中国畜牧兽医,2013,40(9):61~65. 2 Abrams C C, King A M Q, Belsham G J. Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system[J]. Journal of General Virology, 1995, 76(12): 3089~3098. 3 Belsham G J. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure[J]. Prog Biophys Mol Biol, 1993, 60(3): 241~260. 4 Berger I, Fitzgerald D J, Richmond T J. Baculovirus expression system for heterologous multiprotein complexes[J]. Nature Biotechnology, 2004, 22(12): 1583~1587. 5 Bhat S A, Saravanan P, Hosamani M, et al. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge[J]. Research in Veterinary Science, 2013, 95(3): 1217~1223. 6 Cao Y, Lu Z, Sun J, et al. Synthesis of empty capsid-like particles of AsiaⅠfoot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs[J]. Veterinary Microbiology, 2009, 137(1): 10~17. 7 Cao Y, Sun P, Fu Y, et al. Formation of virus-like particles from O-type foot-and-mouth disease virus in insect cells using codon-optimized synthetic genes[J]. Biotechnology Letters, 2010, 32(9): 1223~1229. 8 Catanzariti A M, Soboleva T A, Jans D A, et al. An efficient system for high-level expression and easy purification of authentic recombinant proteins[J]. Protein Science, 2004, 13(5): 1331~1339. 9 Clarke B E, Newton S E, Carroll A R, et al. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein[J]. Nature, 1987, 330(6146): 381~384. 10 Curry S, Abrams C C, Fry E, et al. Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids[J]. Journal of Virology, 1995, 69(1): 430~438. 11 Dong H, Guo H C, Sun S Q. Virus-like particles in picornavirus vaccine development[J]. Applied Microbiology and Biotechnology, 2014, 98(10): 4321~4329. 12 Freivalds J, Dislers A, Ose V, et al. Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris[J]. Protein Expression and Purification, 2011, 75(2): 218~224. 13 Goodwin S, Tuthill T J, Arias A, et al. Foot-and-mouth disease virus assembly: Processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner[J]. Journal of Virology, 2009, 83(21): 11275~11282. 14 Grgacic E V L, Anderson D A. Virus-like particles: Passport to immune recognition[J]. Methods, 2006, 40(1): 60~65. 15 Grillberger L, Kreil T R, Nasr S, et al. Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells[J]. Biotechnology Journal, 2009, 4(2): 186~201. 16 Grote A, Hiller K, Scheer M, et al. JCat: A novel tool to adapt codon usage of a target gene to its potential expression host[J]. Nucleic Acids Research, 2005, 33(suppl 2): W526~W531. 17 Grubman M J, Baxt B. Foot-and-mouth disease[J]. Clinical Microbiology Reviews, 2004, 17(2): 465~493. 18 Gullberg M, Polacek C, Bøtner A, et al. Processing of the VP1/2A junction is not necessary for production of foot-and-mouth disease virus empty capsids and infectious viruses: Characterization of "self-tagged" particles[J]. Journal of Virology, 2013, 87(21): 11591~11603. 19 Guo H C, Sun S Q, Jin Y, et al. Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle[J]. Veterinary Research, 2013, 44(1): 48~60. 20 Jewell J E, Ball L A, Rueckert R. Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A[J]. Journal of Virology, 1990, 64(3): 1388~1393. 21 Kushnir N, Streatfield S J, Yusibov V. Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development[J]. Vaccine, 2012, 31(1): 58~83. 22 Lee C D, Sun H C, Hu S M, et al. An improved SUMO fusion protein system for effective production of native proteins[J]. Protein Science, 2008, 17(7): 1241~1248. 23 Lee C D, Yan Y P, Liang S M, et al. Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli[J]. Journal of Biomedical Science, 2009, 16(1): 69~75. 24 Li Z, Yi Y, Yin X, et al. Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine[J]. PLoS One, 2008, 3(5): e2273. 25 Mackett M, Smith G L. Vaccinia virus expression vectors[J]. Journal of General Virology, 1986, 67(10): 2067~2082. 26 Marblestone J G, Edavettal S C, Lim Y, et al. Comparison of SUMO fusion technology with traditional gene fusion systems: Enhanced expression and solubility with SUMO[J]. Protein Science, 2006, 15(1): 182~189. 27 Mohana Subramanian B, Madhanmohan M, Sriraman R, et al. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency[J]. Antiviral Research, 2012, 96(3): 288~295. 28 Pan L, Zhang Y, Wang Y, et al. Foliar extracts from transgenic tomato plants expressing the structural polyprotein, P1-2A, and protease, 3C, from foot-and-mouth disease virus elicit a protective response in guinea pigs[J]. Veterinary Immunology and Immunopathology, 2008, 121(1): 83~90. 29 Paprocka G. Foot-and-mouth disease vaccines[J]. Medycyna Weterynaryjna, 2013, 69(11): 643~648. 30 Porta C, Xu X, Loureiro S, et al. Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity[J]. Journal of Virological Methods, 2013, 187(2): 406~412. 31 Rodriguez L L, Gay C G. Development of vaccines toward the global control and eradication of foot-and-mouth disease[J]. Expert Review of Vaccines, 2011, 10(3): 377~387. 32 Roldâo A, Mellado M C M, Castilho L R, et al. Virus-like particles in vaccine development[J]. Expert Review of Vaccines, 2010, 9(10): 1149~1176. 33 Roosien J, Belsham G J, Ryan M D, et al. Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors[J]. Journal of General Virology, 1990, 71(8): 1703~1711. 34 Ryan M D, Drew J. Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein[J]. The EMBO Journal, 1994, 13(4): 928~933. 35 Sorensen M A, Kurland C G, Pedersen S. Codon usage determines translation rate in Escherichia coli[J]. Journal of Molecular Biology, 1989, 207(2): 365~377. 36 Sun X H, Baltimore D. Human immunodeficiency virus tat-activated expression of poliovirus protein 2A inhibits mRNA translation[J]. Proceedings of the National Academy of Sciences, 1989, 86(7): 2143~2146. 37 Yusibov V, Rabindran S. Recent progress in the development of plant derived vaccines[J]. Expert Rev Vaccines, 2008, 7(8): 1173~1183. 38 Zhang W, Carmichael J, Ferguson J, et al. Expression of human papillomavirus type 16 L1 protein in Escherichia coli: Denaturation, renaturation, and self-assembly of virus-like particles in vitro[J]. Virology, 1998, 243(2): 423~431. 39 zur Megede J, Chen M C, Doe B, et al. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene[J]. Journal of Virology, 2000, 74(6): 2628~2635. |